Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Lisata Therapeutics' Third Quarter 2024 Financial Results and Business Update Conference Call.
Lisata Therapeutics Inc. (LSTA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 103,622 | $310,866 | +2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.89 | 33,785 | Director | 146,839 | 2021-12-08 | Filing | |
| $1.80 | 55,525 | Director | 106,588 | 2020-09-09 | Filing | |
| $1.40 | 20,000 | Officer, Director | 259,543 | 2015-08-17 | Filing | |
| $1.35 | 12,385 | Officer, Director | 228,750 | 2015-08-12 | Filing | |
| $1.24 | 81,000 | Officer, Director | 216,365 | 2015-08-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.77 | 6,575 | Director | 172,223 | 2017-02-07 | Filing | |
| $4.75 | 500 | Director | 178,798 | 2017-02-06 | Filing | |
| $4.76 | 1,525 | Director | 179,298 | 2017-02-03 | Filing | |
| $4.75 | 1,400 | Director | 180,823 | 2017-02-02 | Filing | |
| $4.51 | 5,000 | Director | 182,223 | 2017-02-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 269,839 | $736,660 | 0.55% | |
| 2. | 176,965 | $483,114 | 0% | |
| 3. | 56,250 | $153,563 | 0% | |
| 4. | 43,390 | $118,486 | 0% | |
| 5. | 33,749 | $92,135 | 0% |
News See All
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Lisata Therapeutics Second Quarter 2024 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Lisata Therapeutics First Quarter 2024 Financial Results and Business Update Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions].
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q4 2023 Earnings Call Transcript
Lisata Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.66, expectations were $-0.86.
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Lisata Therapeutics Third Quarter 2023 Financial Results and this is a day conference call. Currently, all participants are in a listen-only mode.
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Lisata Therapeutics Second Quarter 2023 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Lisata Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in listen-only mode.